Analysts at StockNews.com initiated coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Get Rating) in a research note issued on Thursday. The firm set a “hold” rating on the biotechnology company’s stock. Aptevo Therapeutics Trading Up 0.6 % APVO stock opened at $1.70 on Thursday. Aptevo Therapeutics has a 1-year low of $1.53 and a […]
Analysts’ new coverage for Thursday, May 18th: StockNews.com initiated coverage on shares of Agilent Technologies (NYSE:A). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Alcoa (NYSE:AA). They issued a sell rating on the stock. StockNews.com began coverage on shares of American Airlines Group (NASDAQ:AAL). StockNews.com issued a buy […]
StockNews.com started coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Get Rating) in a report issued on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Aptevo Therapeutics Price Performance Shares of NASDAQ APVO opened at $1.61 on Wednesday. The firm’s 50-day moving average price is $1.86 and its 200-day moving […]
Company Achieves Multiple Clinical and Preclinical Milestones and Raises $9.7 Million in Non-Dilutive Funding, Eliminates Balance Sheet DebtIntroduces Novel Compound APVO711, Dual Mechanism of Action Includes